Thesis work, 45 credits - Structure elucidation by Mass spectrometry
We are offering an exciting master’s thesis project focused on advanced mass spectrometry techniques, specifically MS/MS fragmentation mechanisms. If you are passionate about chemistry, physics, and hands-on technical lab work, this is an excellent opportunity to gain in-depth experience in cutting-edge research.
About AstraZeneca:
AstraZeneca is a global, science-led, patient-centred biopharmaceutical company focusing on discovering, developing, and commercialising prescription medicines for some of the world’s most serious diseases. But we’re more than a global leading pharmaceutical company. At AstraZeneca, we're dedicated to being a Great Place to Work and empowering employees to push the boundaries of science and fuel their entrepreneurial spirit.
About the Opportunity:
As a Thesis Worker at AstraZeneca, you’ll find an environment that’s full of unique opportunities and exciting challenges. Here, you’ll have the opportunity to pursue your areas of interest whilst equally developing a broad skillset and knowledge base to get the best out of your experience. You’ll be working on meaningful projects to make an impact and deliver real value for our patients and our business.
Thesis Work Description:
In this thesis, you will investigate MS/MS fragmentation using alternative activation mechanisms. The primary techniques will include UVPD (Ultraviolet Photodissociation), with a focus on setting up and controlling a 193nm EXCIMER laser within an FT-ICR-MS instrument. You will also compare UVPD results with EID/EAD (Electron-Induced Dissociation/Activation) and CID (Collision-Induced Dissociation).
Essential Requirements:
- Ongoing Master's Degree studies in relevant discipline
- Good basic knowledge in mass spectrometry
- Strong interest in chemistry and physics
- Strong interest in practical and technical lab work
So, what’s next?
Apply today and take the chance to be part of making a difference, making connections, and gaining the tools and experience to open doors and fulfil your potential. We can´t wait to hear from you!
We welcome your application as soon as possible, but ahead of the scheduled closing date 31st of October 2024. In the event that we identify suitable candidates ahead of the scheduled closing date, we reserve the right to withdraw the vacancy earlier than published.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.
